18F-FDG PET in recurrent medullary thyroid carcinoma.

被引：0
|
作者：
Bruno, A [1 ]
Castellani, M [1 ]
Verga, U [1 ]
Schiavini, M [1 ]
Leo, R [1 ]
Gerundini, P [1 ]
机构：
[1] Osped Maggiore, IRCCS, Milan, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 2001年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1337
引用
收藏
页码：322P / 322P
页数：1
相关论文
共 50 条
  • [21] Predictive Value of 18F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib
    Werner, Rudolf A.
    Schmid, Jan-Stefan
    Higuchi, Takahiro
    Javadi, Mehrbod S.
    Rowe, Steven P.
    Maerkl, Bruno
    Aulmann, Christoph
    Fassnacht, Martin
    Kroiss, Matthias
    Reiners, Christoph
    Buck, Andreas K.
    Kreissl, Michael C.
    Lapa, Constantin
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 756 - 761
  • [22] The Role of 18FDG PET in Patients With Recurrent Thyroid Medullary Carcinoma
    Urhan, M.
    Mavi, A.
    Houseni, M.
    Alavi, A.
    Mandel, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S158 - S158
  • [23] Comparison of 68Ga-somatostatin Analogues, 18F-DOPA and 18F-FDG PET/CT in Patients with Recurrent Medullary Thyroid Carcinoma
    Treglia, Giorgio
    Castaldi, Paola
    Villani, Maria Felicia
    Filice, Angelina
    Ambrosini, Valentina
    Cremonini, Nadia
    Salvo, Diana
    Fanti, Stefano
    Giordano, Alessandro
    Rufini, Vittoria
    PANCREAS, 2012, 41 (02) : 349 - 350
  • [24] Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma
    Treglia, Giorgio
    Castaldi, Paola
    Villani, Maria Felicia
    Perotti, Germano
    de Waure, Chiara
    Filice, Angelina
    Ambrosini, Valentina
    Cremonini, Nadia
    Santimaria, Monica
    Versari, Annibale
    Fanti, Stefano
    Giordano, Alessandro
    Rufini, Vittoria
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (04) : 569 - 580
  • [25] Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma
    Giorgio Treglia
    Paola Castaldi
    Maria Felicia Villani
    Germano Perotti
    Chiara de Waure
    Angelina Filice
    Valentina Ambrosini
    Nadia Cremonini
    Monica Santimaria
    Annibale Versari
    Stefano Fanti
    Alessandro Giordano
    Vittoria Rufini
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 569 - 580
  • [26] THE COMBINED USE OF CALCITONIN DOUBLING TIME AND 18F-FDG PET/CT IMPROVES PROGNOSTIC VALUES IN MEDULLARY THYROID CARCINOMA: THE CLINICAL UTILITY OF 18F-FDG PET/CT
    Yang, Ji H.
    Camacho, Cleber P.
    Lindsey, Susan C.
    Valente, Flavia O. F.
    Andreoni, Danielle M.
    Yamaga, Lilian Y.
    Wagner, Jairo
    Biscolla, Rosa Paula M.
    Maciel, Rui M. B.
    ENDOCRINE PRACTICE, 2017, 23 (08) : 942 - 948
  • [27] 18F-FDG PET/CT in Primary and Recurrent Adrenocortical Carcinoma
    Shamim, S.
    Arora, G.
    Hussain, J.
    Gupta, S. Datta
    Kumar, R.
    Bal, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S576 - S577
  • [28] Interest of 18F-FDG PET/CT in anaplastic thyroid carcinoma
    Poisson, Thomas
    Deandreis, Desiree
    Leboulleux, Sophie
    Bidault, Francois
    Bonniaud, Guillaume
    Baillot, Sylvain
    Lumbroso, Jean
    Baudin, Eric
    Schlumberger, Martin
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [29] 18F-FDG PET/CT in Cystic Papillary Thyroid Carcinoma
    Foppiani, Luca
    Morbini, Patrizia
    Catrambone, Ugo
    Fiz, Francesco
    Piccardo, Arnoldo
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (08) : 771 - 773
  • [30] Role of 18F-FDG PET/CT in differentiated thyroid carcinoma
    Craciun, D.
    Alexa, M.
    Mazilu, C.
    Mazilu, A.
    Oancea, M.
    Goldstein, A.
    Voicu, G.
    Neagu, D.
    Chiriac, I.
    Mititelu, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S559 - S560
12345